Most cited papers from Bionovo (United States)
What are the most cited papers from Bionovo (United States)?
The most cited paper from Bionovo (United States) is "In vitro anticancer activity of twelve Chinese medicinal herbs" (Mark Shoemaker, Bobbi Hamilton, Schanaz H. Dairkee et al., 2005), with 231 citations. Next come "Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist" (196) and "Regulation of specific target genes and biological responses by estrogen receptor subtype agonists" (106).
Showing 34 of 34 papers. Every paper is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | In vitro anticancer activity of twelve Chinese medicinal herbs Mark Shoemaker, Bobbi Hamilton, Schanaz H. Dairkee et al. · Phytotherapy Research | Jul 2005 | 231 |
| 2 | Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist Jennifer E. Mersereau, Nitzan Levy, Richard E. Staub et al. · Molecular and Cellular Endocrinology | 27 Nov 2007 | 196 |
| 3 | Regulation of specific target genes and biological responses by estrogen receptor subtype agonists Dale C. Leitman, Sreenivasan Paruthiyil, Omar I. Vivar et al. · Current Opinion in Pharmacology | 15 Oct 2010 | 106 |
| 4 | Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes Kristine E. Ensrud, Katie L. Stone, TERRI L. BLACKWELL et al. · Menopause The Journal of The North American Menopause Society | Mar 2009 | 105 |
| 5 | Estrogen Receptor β Binds to and Regulates Three Distinct Classes of Target Genes Omar I. Vivar, Xiaoyue Zhao, Elise F. Saunier et al. · Journal of Biological Chemistry | 20 Apr 2010 | 102 |
| 6 | Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer Hope S. Rugo, Emma Shtivelman, Alejandra Perez et al. · Breast Cancer Research and Treatment | 16 Nov 2006 | 100 |
| 7 | A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer Alejandra Perez, Banu Arun, Debu Tripathy et al. · Breast Cancer Research and Treatment | 6 Jan 2010 | 93 |
| 8 | Reduction of MTT by aqueous herbal extracts in the absence of cells Mark Shoemaker, Isaac V. Cohen, Michael J. Campbell · Journal of Ethnopharmacology | 12 Jun 2004 | 93 |
| 9 | Timosaponin AIII Is Preferentially Cytotoxic to Tumor Cells through Inhibition of mTOR and Induction of ER Stress Frank W. King, Sylvia Fong, Chandi A Griffin et al. · PLoS ONE | 29 Sep 2009 | 81 |
| 10 | Selective Activation of Estrogen Receptor-β Transcriptional Pathways by an Herbal Extract Aleksandra Čvoro, Sreenivasan Paruthiyil, Jeremy O. Jones et al. · Endocrinology | 9 Nov 2006 | 76 |
| 11 | Drug and Cell Type-Specific Regulation of Genes with Different Classes of Estrogen Receptor β-Selective Agonists Sreenivasan Paruthiyil, Aleksandra Čvoro, Xiaoyue Zhao et al. · PLoS ONE | 16 Jul 2009 | 69 |
| 12 | Estrogen receptor β causes a G2 cell cycle arrest by inhibiting CDK1 activity through the regulation of cyclin B1, GADD45A, and BTG2 Sreenivasan Paruthiyil, Aleksandra Čvoro, Mary Ann Tagliaferri et al. · Breast Cancer Research and Treatment | 30 Nov 2010 | 67 |
| 13 | MF101, a selective estrogen receptor β modulator for the treatment of menopausal hot flushes Deborah G. Grady, George F. Sawaya, Karen Johnson et al. · Menopause The Journal of The North American Menopause Society | May 2009 | 57 |
| 14 | Identification and Analysis of the Active Phytochemicals from the Anti-Cancer Botanical Extract Bezielle Vivian Chen, Richard E. Staub, Scott Baggett et al. · PLoS ONE | 17 Jan 2012 | 50 |
| 15 | Bezielle Selectively Targets Mitochondria of Cancer Cells to Inhibit Glycolysis and OXPHOS Vivian Chen, Richard E. Staub, Sylvia Fong et al. · PLoS ONE | 3 Feb 2012 | 46 |
| 16 | Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells Sylvia Fong, Mark Shoemaker, Jaclyn Cadaoas et al. · Cancer Biology & Therapy | Apr 2008 | 44 |
| 17 | Cell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elements Lonnele J. Ball, Nitzan Levy, Xiaoyue Zhao et al. · Molecular and Cellular Endocrinology | 26 Nov 2008 | 37 |
| 18 | CC3/TIP30 regulates metabolic adaptation of tumor cells to glucose limitation Vivian Chen, Emma Shtivelman · Cell Cycle | 15 Dec 2010 | 37 |
| 19 | Selective concomitant inhibition of mTORC1 and mTORC2 activity in estrogen receptor negative breast cancer cells by BN107 and oleanolic acid Ruth A. Chu, Xiaoyue Zhao, Chandi A Griffin et al. · International Journal of Cancer | 21 Dec 2009 | 36 |
| 20 | Tissue-Specific Regulation of Genes by Estrogen Receptors Dale C. Leitman, Sreenivasan Paruthiyil, Chaoshen Yuan et al. · Seminars in Reproductive Medicine | 2012 | 32 |
| 21 | Oxidative in Vitro Metabolism of Liquiritigenin, a Bioactive Compound Isolated from the Chinese Herbal Selective Estrogen β-Receptor Agonist MF101 René Kupfer, Leah A. Swanson, Sylvia Chow et al. · Drug Metabolism and Disposition | Aug 2008 | 32 |
| 22 | Estrogen Receptor β-Selective Agonists Stimulate Calcium Oscillations in Human and Mouse Embryonic Stem Cell-Derived Neurons Lili Zhang, Brigitte E. Blackman, Marcus D. Schonemann et al. · PLoS ONE | 27 Jul 2010 | 31 |
| 23 | Bezielle (BZL101)‐induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: A combined proteomic and metabolomic study Jelena Klawitter, Jelena Klawitter, Jost Klawitter et al. · International Journal of Cancer | 3 Feb 2011 | 25 |
| 24 | Unliganded estrogen receptor-β regulation of genes is inhibited by tamoxifen Nitzan Levy, Sreenivasan Paruthiyil, Xiaoyue Zhao et al. · Molecular and Cellular Endocrinology | 9 Sep 2009 | 22 |
| 25 | Estrogenic Plant Extracts Reverse Weight Gain and Fat Accumulation without Causing Mammary Gland or Uterine Proliferation Elise F. Saunier, Omar I. Vivar, Andrea Rubenstein et al. · PLoS ONE | 7 Dec 2011 | 12 |
| 26 | Background Adjustment for DNA Microarrays Using a Database of Microarray Experiments Yunxia Sui, Xiaoyue Zhao, Terence Paul Speed et al. · Journal of Computational Biology | Nov 2009 | 11 |
| 27 | CC3/TIP30 affects DNA damage repair Sylvia Fong, Frank W. King, Emma Shtivelman · BMC Cell Biology | 7 Apr 2010 | 10 |
| 28 | Is a shorter hot flash diary just as good as a 7-day diary? Deborah G. Grady, Judith L. Macer, Margaret Kristof et al. · Menopause The Journal of The North American Menopause Society | 29 Aug 2009 | 8 |
| 29 | Clinically meaningful efficacy of a non-estrogen agent: re-analysis of phase-2 data evaluating MF101 Mary Ann Tagliaferri, Jennifer M. Creasman, Katherine A. Caygill et al. · Climacteric | 18 Jan 2012 | 4 |
| 30 | Norlignans from Anemarrhenae asphoeloides Displaying Selective Estrogen Beta (ER?) Activity Hsiu‐Wen Yang, Scott Baggett, Richard E. Staub et al. · Planta Medica | Feb 2008 | 1 |
| 31 | Structural Elucidation of Four Mono-methyl Isoflavone Analogs Scott Baggett, Ramesh Chimmani, Suetying Chow et al. · Planta Medica | Feb 2008 | 1 |
| 32 | Prioritizing Disease Genes and Understanding Disease Pathways Xiaoyue Zhao, Lilia M. Iakoucheva, Michael Q. Zhang · IGI Global eBooks | 2009 | 0 |
| 33 | Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata D. Don, towards breast cancer cells Sylvia Fong, Mark Shoemaker, Jaclyn Cadaoas et al. · Molecular Cancer Therapeutics | Nov 2007 | 0 |
| 34 | Identification of a Novel Class of Estrogen Receptor b-Selective Compounds Jordan E. Jackson, Richard E. Staub, Scott Baggett et al. · Fertility and Sterility | Sep 2005 | 0 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.